Add BrightSurf on Google Email

Kindai University


‘Mobile’ DNA elements may have expanded gene regulatory networks in brain development

A study found that transposable elements, once considered non-functional DNA, contribute to the evolution and expansion of gene regulation during neural development. The findings suggest a two-phase model of TE acquisition during evolution, involving both ancient and more recent expansions that shaped modern gene regulatory networks.

SourceKindai University·JournalGenome Biology·TypeData/statistical analysis·DateMay 12, 2026

Integration of two genes: A valuable strategy for developing virus-resistant tomatoes

Researchers discovered a combination of Ty-1/Ty-3 and Ty-6 resistance genes in tomato plants provides highly robust protection against begomoviruses. Integration of fewer resistance genes than expected can enhance resistance, offering a promising approach for improving tomato varieties while balancing productivity and fruit quality.

SourceKindai University·JournalEuphytica·TypeExperimental study·DateApr 14, 2026

A single gene underlies begomovirus resistance in eggplant

A study at Kindai University has identified a single gene in eggplant that provides resistance to begomovirus infection. This finding holds promise for developing naturally protected crop varieties, reducing the need for insecticides and promoting sustainable food production.

SourceKindai University·JournalTheoretical and Applied Genetics·TypeExperimental study·DateJan 9, 2026

Inflammation-induced metabolic shifts linked to brain disorders

A study published in the Journal of Proteome Research found that acute systemic inflammation causes region-specific metabolic disruption in the cerebrum, impairing neuronal metabolism. Key findings include reduced NAA levels and elevated urea accumulation, suggesting a link between inflammation and neurodegenerative disorders.

SourceKindai University·JournalJournal of Proteome Research·TypeExperimental study·DateDec 19, 2025

Reducing the global burden of liver cancer: Recommendations from The Lancet commission

The Lancet commission emphasizes the need for concrete goals to reduce hepatocellular carcinoma's growing disease burden. The authors propose a 2% annual reduction in age-standardized incidence rates and recommend evidence-based strategies to tackle viral hepatitis, alcohol consumption, environmental risk factors, and disparities in he...

SourceKindai University·JournalThe Lancet·TypeMeta-analysis·DateAug 8, 2025

Hope for a complete cure for hepatocellular carcinoma: Combining lenvatinib and pembrolizumab with transarterial chemoembolization improves efficacy in treating hepatocellular carcinoma

A phase 3 study found that combining lenvatinib and pembrolizumab with transarterial chemoembolization significantly extended progression-free survival and showed a trend toward extending overall survival in patients with unresectable non-metastatic hepatocellular carcinoma. The treatment may lead to a complete cure.

SourceKindai University·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateMar 23, 2025

Shaking it up: An innovative method for culturing microbes in static liquid medium

Researchers have developed a novel method for culturing bacteria in a static liquid medium, eliminating the need for shaking and subjecting microorganisms to physical stress. This new method enables easy observation of biological phenomena and has potential applications in various fields such as education, healthcare, and industry.

SourceKindai University·JournalScientific Reports·TypeExperimental study·DateNov 8, 2024

Using mice to understand the link between prostate cancer and gut bacteria

A recent study published in The Prostate used genetically modified mice to investigate the relationship between gut dysbiosis and prostate cancer. The researchers found that both humans and mice exhibited marked differences in their gut microbiome composition, with certain bacteria positively associated with prostate cancer. Additional...

SourceKindai University·JournalThe Prostate·TypeObservational study·DateOct 7, 2024

Revolutionizing cell biology: first-ever artificial cell nuclei created in living egg from purified DNA injection

A team of researchers has successfully created the first artificial cell nuclei in living mouse eggs by injecting purified DNA, revealing key mechanisms behind nucleus formation. The study provides crucial insights into nuclear function and structure, with potential applications in reviving extinct animals and creating artificial life.

SourceKindai University·JournalGenes to Cells·TypeExperimental study·DateOct 2, 2024

Studying the intricacies of homologous recombination and abnormal chromosome bridges

A recent study investigated the relationship between RAD51 and FIGNL1, shedding light on the intricacies of homologous recombination. The results reveal that FIGNL1 is essential for proper chromosome separation after replication forks are dismantled, preventing abnormal chromosome bridges that can lead to genetic instability.

SourceKindai University·JournalNucleic Acids Research·TypeExperimental study·DateMay 7, 2024

Elucidating the link between Guillain–Barré syndrome and Takotsubo cardiomyopathy

A recent study investigates the correlation between Takotsubo cardiomyopathy (TCM) and Guillain–Barré syndrome (GBS), revealing key factors that distinguish TCM patients from those with classical GBS. The researchers identified age at onset, disability scores, muscle weakness, and cranial nerve involvement as significant differences.

SourceKindai University·JournalJournal of Neurology·TypeData/statistical analysis·DateApr 11, 2024

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy and assessing t-cell exhaustion

Researchers developed a novel assay to study immune checkpoint molecules in blood plasma, finding elevated concentrations in patients with immune-reactive tumors who were nonresponsive to PD-1/PD-L1 blockade therapy. Soluble factors correlated with exhausted antitumor immunity and predicted therapy efficacy.

SourceKindai University·JournalJournal of Clinical Investigation·TypeRandomized controlled/clinical trial·DateApr 1, 2024